Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis ...

Class IIb CE marking is a prerequisite for Median’s eyonis ® LCS Software as a Medical Device marketing in Europe Lung cancer screening programs are already implemented in several European countries, ...

(Euronext Growth Paris™- ISIN: FR0000072373 - Ticker: ALGID), worldwide provider of hermetic packages and connectors and heat dissipation solutions for sensitive electronic components, announces that ...

Eurobio Scientific completes the acquisition of Life Science unit of Voden Medical Instruments Spa in Italy Paris, July 1st, 2025 Eurobio Scientific (FR0013240934, ALERS), (FR0013240934, ALERS, ...

Eurobio Scientific finalise l'acquisition de l'unité Sciences de la vie de Voden Medical Instruments Spa en Italie Paris, le 1er Juillet 2025 –17h45 Eurobio Scientific (FR0013240934, ALERS, éligible ...

Ageas announced today that all necessary regulatory approvals for the acquisition of Acromas Insurance Company Limited (AICL), Saga’s Underwriting Business, have been obtained and the transaction has ...

Resumption of CARMAT shares trading starting July 2, 2025, at stock market opening Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial ...

Information on share capital and voting rights June 2025 Statement made in accordance with article L. 233-8 II of the French commercial Code and articles 221-1 2 ° f) and 223-16 of the AMF Regulations ...

Aurora Eiendom AS (AURA) (the “Company”) refers to earlier stock exchange announcements in connection with the proposed voluntary delisting from Euronext Growth Oslo, and the voluntary cash offer (the ...

Reference is made to the following disclosures by IDEX Biometrics ASA: 15 June 2025: Issue of 299,381,600 new shares to employees, contractors and directors in IDEX. 23 June 2025: Issue of 5,412,932 ...

Evolution of the accounting treatment of Renault Group's stake in Nissan Renault Group's stake in Nissan, which was previously accounted for under the equity method, will be treated as a financial ...

Educational programme for individual investors in collaboration with key market players This section aims to provide retail investors with the fundamental, financial information, enhancing ...